Warner Music Group Corp. Announces Quarterly Cash Dividend NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Warner Music Group Corp. (“Warner Music Group” or “WMG”) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.17 per share on WMG’s Class A Common Stock and Class B Common Stock. The dividend is payable on June 3, 2024, to stockholders of record as of the close of business on May 23, 2024. About Warner Music Group With a legacy extending back over 200 years, Warner Music Group today is home to an unparalleled family of creative artists, songwriter...
NEW YORK--(BUSINESS WIRE)-- American Express Company (NYSE: AXP) today announced its participation in upcoming investor conferences. On Thursday, May 30, 2024, Chairman and CEO Stephen J. Squeri will participate in a fireside chat at Bernstein’s 40th Annual Strategic Decisions Conference. Mr. Squeri will address questions relating to the company’s business strategy and financial performance beginning at 2:30 p.m. (ET). On Wednesday, June 12, 2024, Chief Financial Officer Christophe Le Caillec will participate in a fireside chat at the Morgan Stanley US Financials, Payments & Commercial Rea...
A director at Capital One Financial Corp sold 16,913 shares at 142.880USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights Dosing of first patient with NKX019 for lupus nephritis using disease-tailored lymphodepletion expected in first half of 2024Cash balance of $450.0 million on March 31, 2024, including cash, cash equivalents and investmentsStrong balance sheet, bolstered by recent $240.1 million offering, expected to fund operations into late 2027 SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell the...
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results Presented positive 72-week data from the Phase 2b ORIGIN clinical trial, setting a new standard in IgAN with no loss of kidney function over the duration of treatmentTopline 96-week data from ORIGIN 2 trial expected in Q4 2024Pivotal Phase 3 ORIGIN 3 trial estimated to complete enrollment for primary endpoint in Q3 2024; topline data expected in 1H 2025Completed $287.5 million financing, further strengthening the Company’s balance sheet BRISBANE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Vera Thera...
Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2024 Financial Highlights Solid Results Driven by Growth Across Recorded Music and Music Publishing Recorded Music Results Underpinned by an Acceleration in Subscription StreamingMusic Publishing Delivered Revenue Growth of 19%Reiterating Full-Year Operating Cash Flow Conversion Guidance of 50-60% For the three months ended March 31, 2024 Total revenue increased 7%, the same in constant currencyNet income was $96 million versus $37 million in the prior-year quarterOperating income decreased 4% to $119 mil...
WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2024. For the quarter, revenue was $1.01 billion, a decrease of 1.7% from $1.03 billion in the first quarter of 2023. The impact of foreign currency translation benefited reported revenue by 0.3%, and acquisitions contributed 1.5% to consolidated first-quarter revenue. A small divestiture of a Safety Assessment site reduced reported revenue by 0.2%. Excluding the effect of these items, organic revenue decreased 3.3%. On a segment basis, both the ...
Two Directors at American Express Co sold after exercising options/sold 6,733 shares at between 230.930USD and 232.360USD. The significance rating of the trade was 93/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by al...
NEW YORK--(BUSINESS WIRE)-- The Board of Directors of American Express Company (NYSE: AXP) has declared a quarterly dividend on the Company’s 3.550% Fixed Rate Reset Noncumulative Preferred Shares, Series D, of $9,269.44 per share (which is equivalent to $9.26944 per related Depositary Share). The dividend is payable on June 17, 2024 to shareholders of record on June 1, 2024. The Board also declared a regular quarterly dividend of $0.70 per common share, payable on August 9, 2024, to shareholders of record on July 5, 2024. ABOUT AMERICAN EXPRESS American Express is a globally integrated ...
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 1, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 15,000 shares of Class A common stock and restricted stock units (RSUs) for 7,500 shares of Class A common stock to three new employees under Vera’s 2024 Inducement Plan (the Inducement Plan). Vera also announced that on May 6, 2024, the Compensation ...
A director at Moog Inc sold 5,250 shares at 160.800USD and the significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Credit markets are overstating credit risk with a YTW of 6.853% relative to an Intrinsic YTW of 6.083% and an Intrinsic CDS of 139bps. Meanwhile, credit markets are materially overstating the firm's fundamental credit risk, with its Ba3 credit rating five notches lower than Valens' IG4+ (Baa1) credit rating. Incentives Dictate Behavior™ analysis highlights mixed signals for credit holders. As a positive, management members are material owners of PBF equity relative to their annual compensation,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.